Unknown

Dataset Information

0

Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.

ABSTRACT: Hyper-IgE syndrome (HIES) is a rare primary immunodeficiency characterized by elevated levels of immunoglobulin E (IgE), eczematous dermatitis, cold abscesses, and recurrent infections of the lung and skin caused by Staphylococcus aureus. The dominant form is characterized by nonimmunologic features including skeletal, connective tissue, and pulmonary abnormalities in addition to recurrent infections and eczema. Omalizumab is a humanized recombinant monoclonal antibody against IgE. Several studies reported clinical improvement with omalizumab in patients with severe atopic eczema with high serum IgE level. We present the case of a 37-year-old male with HIES and cutaneous manifestations, treated with humanized recombinant monoclonal antibodies efalizumab and omalizumab. After therapy for 4 years, we observed diminished eczema and serum IgE levels.

SUBMITTER: Alonso-Bello CD 

PROVIDER: S-EPMC6637684 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Hyper-IgE syndrome (HIES) is a rare primary immunodeficiency characterized by elevated levels of immunoglobulin E (IgE), eczematous dermatitis, cold abscesses, and recurrent infections of the lung and skin caused by <i>Staphylococcus aureus</i>. The dominant form is characterized by nonimmunologic features including skeletal, connective tissue, and pulmonary abnormalities in addition to recurrent infections and eczema. Omalizumab is a humanized recombinant monoclonal antibody against IgE. Severa  ...[more]

Similar Datasets

Unknown Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review.
| S-EPMC9114644 | biostudies-literature
Unknown Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome.
| S-EPMC8171578 | biostudies-literature
Unknown Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
| S-EPMC2878129 | biostudies-literature
Unknown Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome.
| S-EPMC4641001 | biostudies-literature
Unknown STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome.
| S-EPMC5966547 | biostudies-literature
Unknown Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.
| S-EPMC8217968 | biostudies-literature
Unknown Molecular Assessment of Staphylococcus Aureus Strains in STAT3 Hyper-IgE Syndrome Patients.
| S-EPMC9537231 | biostudies-literature
Unknown Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
| S-EPMC2871547 | biostudies-literature
Unknown Unraveling the unphosphorylated STAT3-unphosphorylated NF-κB pathway in loss of function STAT3 Hyper IgE syndrome.
| S-EPMC11369709 | biostudies-literature
Unknown Respiratory syncytial virus reduces STAT3 phosphorylation in human memory CD8 T cells stimulated with IL-21.
| S-EPMC6882881 | biostudies-literature